Vinati Organics ATBS expansion and VOPL ramp-up set to drive earnings growth

Investment View and Valuation

Motilal Oswal Financial Services Ltd. retained its Buy recommendation on Vinati Organics in its July 29, 2026, 1QFY27 result update. The broker's central thesis is that earnings should be driven by the ramp-up of ATBS capacity and a larger contribution from Veeral VOPL.

Motilal Oswal values Vinati Organics at 28 times FY28E EPS to derive a target price of Rs 1,550, compared with the report CMP of Rs 1,305.

1QFY27 Financial Performance

Vinati Organics reported 1QFY27 revenue of about Rs 7,000 million, up 28 per cent year-on-year and 15 per cent quarter-on-quarter. This was materially ahead of Motilal Oswal's estimate of Rs 5,800 million.

EBITDA was about Rs 1,700 million, up 7 per cent year-on-year and broadly flat sequentially, versus the broker's estimate of Rs 1,600 million. Adjusted PAT was Rs 1,089 million, up 4 per cent year-on-year but down 12 per cent quarter-on-quarter, and was in line with estimates. Motilal Oswal characterised the operating performance as in line overall.

Margin Pressure from Raw-Material Volatility

The key negative in 1QFY27 was margin pressure from volatility in key raw-material prices. Gross margin declined to 46.0 per cent from 52.3 per cent in 1QFY26 and 52.5 per cent in 4QFY26.

EBITDA margin contracted by 500 basis points year-on-year and 370 basis points quarter-on-quarter to 24.5 per cent. The reported revenue outperformance therefore translated into only modest EBITDA growth, highlighting raw-material-price volatility as an important concern for earnings and margins.

ATBS Expansion and Segment Growth Outlook

Motilal Oswal expects the ATBS segment to be the principal growth driver. Vinati Organics is ramping up Phase I of its 10,000 MTPA ATBS capacity expansion, while Phase II, adding a further 10,000 MTPA, is scheduled to be commissioned in October 2026.

The broker expects Vinati Organics to benefit from an anticipated recovery in ATBS demand. It also expects gradual demand improvement in the Butyl Phenol and Isobutyl Benzene segments.

Veeral VOPL Ramp-up

Veeral VOPL is expected to make a meaningful contribution from 2HFY27 as newly commercialised products are ramped up. These products include Anisole, 4-MAP, TAA and PTA and cater to diverse end-user industries.

The principal factors underpinning the broker's outlook are:

• The pace of ATBS capacity ramp-up.
• Commissioning of Phase II of the ATBS expansion in October 2026.
• Recovery in ATBS, Butyl Phenol and Isobutyl Benzene demand.
• Scale-up of Veeral VOPL's newly commercialised products.

Earnings Estimates and Valuation Metrics

Motilal Oswal broadly maintained its FY27 and FY28 earnings estimates. However, its revised forecast raises revenue estimates by 12 per cent for FY27E and 7 per cent for FY28E, while reducing EBITDA, PAT and EPS estimates by 3 per cent to 4 per cent.

The broker forecasts FY26-28 revenue, EBITDA and PAT CAGR of 18 per cent, 15 per cent and 13 per cent, respectively.

At the report CMP, Vinati Organics traded at about 23.8 times FY28E EPS and 15.4 times FY28E EV/EBITDA. Motilal Oswal's target price of Rs 1,550 is based on a valuation of 28 times FY28E EPS.

Key Risks and Dependencies

The investment case remains dependent on delivery of the planned capacity and product ramp-ups, demand improvement in the relevant segments and containment of raw-material-driven margin volatility.